Your browser doesn't support javascript.
loading
Identification of macrotroponin T: findings from a case report and non-reproducible troponin T results.
Lam, Leo; Ha, Leah; Heron, Campbell; Chiu, Weldon; Kyle, Campbell.
Afiliação
  • Lam L; Department of Chemical Pathology, LabPLUS, Auckland City Hospital, Auckland, New Zealand.
  • Ha L; Biochemistry Department, Middlemore Hospital Laboratories, Middlemore Hospital, Auckland, New Zealand.
  • Heron C; Department of Chemical Pathology, LabPLUS, Auckland City Hospital, Auckland, New Zealand.
  • Chiu W; Biochemistry Department, Middlemore Hospital Laboratories, Middlemore Hospital, Auckland, New Zealand.
  • Kyle C; Department of Chemical Pathology, LabPLUS, Auckland City Hospital, Auckland, New Zealand.
Clin Chem Lab Med ; 59(12): 1972-1980, 2021 11 25.
Article em En | MEDLINE | ID: mdl-34496163
ABSTRACT

OBJECTIVES:

Macrotroponin is due to cardiac troponin (cTn) binding to endogenous cTn autoantibodies. While previous studies showed a high incidence of macrotroponin affecting cTnI assays, reports of macrotroponin T, particularly without cTnI reactivity, have been rare. Although the clinical significance of macrotroponin is not fully understood, macroenzymes and complexes are recognised to cause confusion in interpretation of laboratory results. The potential for adverse clinical consequences due to misinterpretation of affected results is very high.

METHODS:

We describe four cases of macrotroponin T with persistently low high sensitivity cTnT (hs-cTnT) by the 9 min compared to the 18 min variant of the assay. Three cases were serendipitously identified due to the use of a lot number of Roche hs-cTnT affected by non-reproducible results, necessitating measurement of cTnT in duplicate. We identified and characterised these macrotroponin specimens by immunoglobulin depletion (Protein A and PEG precipitation), mixing studies with EDTA and recombinant cTnT.

RESULTS:

In cases of macro-cTnT, a lower result occurred on the hs-cTnT using the 9 min compared to 18 min variant assay (ratio of 9-18 min hs-cTnT <0.80). Mixing studies with recombinant cTnT or EDTA demonstrated a difference in recovery vs. controls. One of these patients demonstrated a high molecular weight complex for cTnI and cTnT demonstrating a macrocomplex involving both cTn. This patient demonstrated a rise and fall in cTn when measured by several commercial assays consistent with genuine acute cardiac injury.

CONCLUSIONS:

We identified several cases of macro-cTnT and described associated clinical and biochemical features.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoanticorpos / Bioensaio / Troponina T Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoanticorpos / Bioensaio / Troponina T Idioma: En Ano de publicação: 2021 Tipo de documento: Article